Cenix BioScience has expanded its licensing agreement to deploy Definiens’ image analysis platform for high-content screening.
After an internal review, Definiens Cellenger was reselected as the best available application to support Cenix in the development and implementation of high content (HC) microscopy assays for HT-RNAi studies in cultured human and rodent cells.
By deploying Definiens’ image analysis platform, Cenix BioScience achieves higher hit rates, improved accuracy and greater reliability in its RNA interference research services.
Definiens Cellenger is an application for high content analysis that enables the automated extraction of data from images used in cell-based assays. It allows Cenix to analyse structures of interest even in complex images with high accuracy. The flexible and platform-independent application automates and standardises the company’s image analysis processes - of particular use with multi-parametric cell-based assays.
The application will be integrated into the existing HT/HC-RNAi-based research infrastructure at Cenix, enabling the widest possible range of advanced microscopy-based assays in its research service offerings.